Study, Year | Catheter Type Investigated | Population Size | Venous Catheter Number | Age (yr) | Sex (M/F) | APACHE II/III Score | Antibiotic Prophylaxis | Indwelling time: CRBSI group (Non-CRBSI group) | Colonisation (% total) | CRBSI (% total) |
---|---|---|---|---|---|---|---|---|---|---|
Bijma, 1999 [7] | CVC | 128 | n = 206 | 54 | 59/128 | 20 (II) | - | - | 44 (21.36%)b | 15 (7.28%)b |
 |  | 140 | n = 194 | 54 | 72/140 | 19 (II) | - | - | 25 (12.88%) | 8 (4.12%) |
PAC + CVC | 260 | n = 506 | 65 | 127/133 | 64 (III) | - | 5 (3) | 60 (8.4%) | 17 (2.0%)c | |
Sandoe, 2003 [10] | AC + CVC | 179 | n = 175 | - | - | - | Yes | 6 (4) | 27 (15.1%)d | 0 (0%) |
Pawar, 2004 [11] | CVC | 1314 | n = 1314a | 58.4 | 1166/148 | 6.9 (II) | Yes | 24.5 (6.1) | - | 35 (2.7%) |
Guillou, 2011 [12] | CVC | 7557 | n = 7557a | 65.1 | 5403/2154 | - | - | - | 653 (8.6%) | 40 (0.5%) |
Gunst, 2011 [13] | CVC | 121 | n = 263 | 47 | 69/52 | 22 (II) | Yes | 25 (16) | - | 13 (4.9%) |
 | PICC |  | n = 37 |  |  |  | No | 19 (14) | - | 1 (2.7%) |
Miyagaki, 2011 [14] | PICC | 25 | n = 25a | 65.6 | 24/1 | - | - | - | - | 1 (4%) |